Home/All Molecules/Sulfasalazine

Sulfasalazine Range

Comprehensive Sulfasalazine portfolio for Franchise & Manufacturing.

Category
sulfasalazine
Total Formulations
2
Available Forms
Tablets

Expand Your Business with Our Multiple Divisions


Browse Sulfasalazine portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Sulfasalazine batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Sulfasalazine PCD Pharma Franchise Company

Sulfasalazine PCD Pharma Franchise Company

Cafoli Lifecare offers a Sulfasalazine PCD pharma franchise backed by 2 tablet formulations, manufactured at WHO-GMP certified facilities with DCGI-approved compositions. It is a compact but high-value line for partners working with rheumatology and gastroenterology prescribers.

What is Sulfasalazine?

Sulfasalazine is a conventional disease-modifying anti-rheumatic drug (DMARD) formed by linking sulfapyridine to 5-aminosalicylic acid via an azo bond. Colonic bacteria cleave that bond, releasing 5-ASA which acts locally as an anti-inflammatory in the bowel, while the sulfapyridine moiety is absorbed and contributes to its systemic immunomodulatory effect in joint disease. It is listed on the WHO Model List of Essential Medicines.

Therapeutic Applications of Sulfasalazine

Sulfasalazine is used for the induction and maintenance of remission in ulcerative colitis and in Crohn's disease affecting the colon, and as a DMARD in rheumatoid arthritis, ankylosing spondylitis and other spondyloarthropathies, including juvenile idiopathic arthritis. Prescribers are chiefly rheumatologists and gastroenterologists, supported by consulting physicians. It requires medical supervision with periodic blood count and liver function monitoring.

Why Sulfasalazine is a High-Potential Molecule for Distributors

Sulfasalazine survives commercially for a reason that is structural rather than clinical: biologics have transformed rheumatology in principle, but in a market where most patients pay out of pocket, they remain unaffordable for the majority. Conventional DMARDs therefore retain their place, and sulfasalazine is among the most widely used. Critically, both of its indications — inflammatory bowel disease and inflammatory arthritis — are lifelong, so a patient started on therapy typically continues for years. That yields an unusually long revenue tail per patient from a low-cost, off-patent tablet.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers genuine district monopoly rights, WHO-GMP certified manufacturing, DCGI-approved compositions and complete promotional inputs including visual aids, samples, prescription pads and MR bags. We are trusted by 1000+ franchise partners across India.

References

  1. PubChem – Sulfasalazine compound record
  2. MedlinePlus – Sulfasalazine drug information
  3. WHO Model List of Essential Medicines

Aceclofenac in Modern Clinical Practice

Our formulations of Sulfasalazine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Sulfasalazine in PCD Franchise

Start Your Sulfasalazine Franchise with Cafoli Lifecare

Ready to build your own Sulfasalazine distribution business? Cafoli Lifecare offers monopoly-based PCD pharma franchise rights, WHO-GMP certified manufacturing and complete promotional support. Call 9518447302 or email info@cafoli.in to check district availability and receive our latest price list.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare currently lists 2 Sulfasalazine tablet formulations. Composition, packing and pricing details are shared with prospective franchise partners on enquiry.

Yes. Sulfasalazine is offered on a district monopoly basis, so only one Cafoli franchise partner is appointed per territory, subject to verification of your Drug License.

Sulfasalazine is prescribed by rheumatologists for rheumatoid arthritis and spondyloarthritis, and by gastroenterologists for ulcerative colitis. Consulting physicians also prescribe it where specialists are not locally available.

Cost and access. Biologics remain out of reach for most Indian patients paying out of pocket, so sulfasalazine continues to be a first-line conventional DMARD in rheumatoid arthritis and a maintenance agent in ulcerative colitis. It is a WHO essential medicine, taken for years at a time, which gives it exceptionally long prescription duration per patient.

A valid Drug License and GST registration number are required to begin the appointment process with Cafoli Lifecare.